8-Chloro-2-(methylsulfonyl)pyrido[3,4-d]pyrimidine, 98%, 500mg

Trimethylsulfonium Hydroxide (0.2mol/L in Methanol) [Methylating Reagent]5mL

p-Anisic anhydride, 95.0%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid, 95.0%, 25g

2-(Difluoromethyl)pyridin-4-amine, 97%, 250mg

Par de oculares, tubo de Ø 23,2 mm

4-(2,4-Difluorobenzoyl)isoquinoline, 97.0%, 1g

2,2-Dimethyl-1H-indene-1,3(2H)-dione, 98%, 1g

2,5-Dibromo-4-nitroimidazole, 97.0%, 10g

2-(Pyridin-2-yloxy)ethanamine, 95.0%, 5g

1-methyl-5-(pyrrolidin-3-ylsulfanyl)-1H-1,2,3,4-tetrazole hydrochloride, 95.0%, 500mg

(3-(4-Methylpiperazin-1-yl)phenyl)methanol, 95.0%, 5g

Fmoc-Lys-OH.HCl, 98%, 25g